Marrufo, A. M., Mathew, S. O., Chaudhary, P., Malaer, J. D., Vishwanatha, J. K., & Mathew, P. A. (2018). Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) interaction enhances natural killer cell-mediated lysis of triple-negative breast cancer cells. Am J Cancer Res.

Marrufo, Armando M., Stephen O. Mathew, Pankaj Chaudhary, Joseph D. Malaer, Jamboor K. Vishwanatha, و Porunelloor A. Mathew. "Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) Interaction Enhances Natural Killer Cell-mediated Lysis of Triple-negative Breast Cancer Cells." Am J Cancer Res 2018.

Marrufo, Armando M., et al. "Blocking LLT1 (CLEC2D, OCIL)-NKRP1A (CD161) Interaction Enhances Natural Killer Cell-mediated Lysis of Triple-negative Breast Cancer Cells." Am J Cancer Res 2018.